• Home
  • About
  • Contact
  • Steve Walker
  • Subscriptions
    • Sample MondayMorning Newsletter January 11, 2016
Monday Morning
Skip to content
  • Home
  • About
  • Contact
  • Steve Walker
  • Subscriptions
    • Sample MondayMorning Newsletter January 11, 2016

Tag Archives: Apellis Pharmaceuticals Inc.

Boomer Alert: Aging immune cells increase risk for macular degeneration, blindness. Apellis, Ophthotech to the rescue?

Steve Walker    May 7, 2018 May 7, 2018    No Comments on Boomer Alert: Aging immune cells increase risk for macular degeneration, blindness. Apellis, Ophthotech to the rescue?

The News: As people age, so do their immune systems. And new research at Washington University School of Medicine in St. Louis suggests that aging immune cells increase the risk… Read more »

Disability, Disease, Investment, Pharmaceuticals    Aflibercept, Apellis Pharmaceuticals Inc., Auto-Immune Disease, Brolucizumab, Edit Kovalcsik, Eylea, GlobalData, JCI Insight, Jonathan B. Lin, Lampalizumab, Macrophages, Macular Degeneration, microRNA, Novartis AG, Ophthotech Corp., Paul A. Cibis, Rajendra S. Apte, Regeneron Pharmaceuticals Inc., Roche Holding AG, RTH258, The Pharma Letter, Zimura

Search The Site

Follow @MonMorningNews

Twitter

Tweets by MonMorningNews
Follow me on Blogarama

Facebook

Search The Site

More MondayMorning

  • Recent Posts
  • Most Commented
  • Most Viewed
  • Reducing salt consumption may protect against Alzheimer’s. Considering the stakes, start now.
  • US stock market has a subdued Thanksgiving week, but a slew of healthcare companies rocketed higher.
  • More Chinese medical companies choosing New York over Shanghai, Hong Kong for IPOs; but not always.
  • Health-sector IPO market cools off for Veterans Day breather; but pre-Thanksgiving deals ready to rock.
    • Insys trial opens with tale of sales rep giving lap dance to doctor for fentanyl prescriptions. News organizations seize upon...
    • Voyager Therapeutics signs another neurodegenerative disease deal with AbbVie that screams “Buy this small cap now.”
    • Little known Czech biotech’s cell therapy greatly increases survival in ovarian cancer. Sotio’s potential breakthrough and another pipeline cancer candidate...
    • Powered only by heart muscle, experimental pacemaker doesn’t need new batteries. Goodbye (hopefully) to battery-replacement surgery; but hello international patent...
    Copyright 2018
    Ribosome by GalussoThemes.com
    Powered by WordPress